This single-award Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult influenza vaccines for the 2022-2023 flu season. The contract has a ceiling value of $65,825,903.80 and a period of performance from the date of award on December 31, 2021 through February 28, 2023.
The original solicitation sought proposals for IDIQ contracts to supply a minimum of 100 doses and a maximum of 20 million doses of inactivated influenza vaccine for individuals aged 19 years and older. Vaccines must be FDA-licensed and manufactured according to cGMP regulations. Deliveries will be FOB Destination to CDC distribution centers in Colorado and Tennessee, as well as potential deliveries to five CDC occupational health clinics. This acquisition was conducted under FAR Part 12 for commercial items, with no set-aside designations. The NAICS code is 325412, Pharmaceutical Preparation Manufacturing and the PSC code is 6505, Drugs/Biologics.
Generated 8/1/24, 9:17 AM